Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 21.


Psarelli, EE ORCID: 0000-0002-3102-0288, Jackson, R, Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Ghaneh, P, Halloran, CM ORCID: 0000-0002-5471-4178 and Buechler, MW
(2017) Beyond ESPAC-4: better surgery and systemic therapy. LANCET, 389 (10078). pp. 1517-1518.


Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Ghaneh, P, Psarelli, EE ORCID: 0000-0002-3102-0288, Valle, JW, Halloran, CM ORCID: 0000-0002-5471-4178, Faluyi, O, O'Reilly, DA, Cunningham, D, Wadsley, J
et al (show 24 more authors) (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet (London, England), 389 (10073). 1011 - 1024.


Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Ghaneh, P, Psarelli, EE ORCID: 0000-0002-3102-0288, Valle, JW, Halloran, CM ORCID: 0000-0002-5471-4178, Faluyi, O, O'Reilly, DA, Cunningham, D, Wadsley, J
et al (show 24 more authors) (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet (London, England), 389 (10073). pp. 1011-1024.


Halloran, CM ORCID: 0000-0002-5471-4178
(2018) Cytoplasmic HuR Status Predicts Disease-Free Survival in Resected Pancreatic Cancer: A Post-Hoc Analysis from the International Multi-Institutional Phase III ESPAC-3 Clinical Trial. Annals of Surgery, 267 (2). pp. 364-369.


Oldfield, L ORCID: 0000-0002-0839-402X, Rao, R, Purewal, T, Neoptolemos, JP, Halloran, CM ORCID: 0000-0002-5471-4178, Greenhalf, W and Costello, E
(2017) Detecting Pancreatic Cancer Earlier: Identifying Type 3c Diabetes in Individuals Newly Diagnosed With Type 2 Diabetes. .


Elander, NO, Aughton, K ORCID: 0000-0002-5184-5789, Ghaneh, P, Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Cox, TF, Campbell, F, Costello-Goldring, E ORCID: 0000-0002-0104-8992, Halloran, CM ORCID: 0000-0002-5471-4178, Mackey, JR
et al (show 16 more authors) (2018) Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predict survival in pancreatic cancer. British Journal of Cancer, 118 (7). pp. 947-954.


Halloran, CM ORCID: 0000-0002-5471-4178
(2018) Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer. JNCI: Journal of the National Cancer Institute, 118 (7). pp. 947-954.


Drewes, Asbjørn M, Bouwense, Stefan AW, Campbell, Claudia M, Ceyhan, Güralp O, Delhaye, Myriam, Demir, Ihsan Ekin, Garg, Pramod K, van Goor, Harry, Halloran, CM ORCID: 0000-0002-5471-4178, Isaji, Shuiji
et al (show 9 more authors) (2017) Guidelines for the understanding and management of pain in chronic pancreatitis. Pancreatology, 17 (05). pp. 720-731.


Halloran, CM
(2000) High expression of intra-tumoral dihydropyrimidine dehydrogenase is a negative prognostic factor in patients treated with adjuvant 5-fluorouracil based chemotherapy following resection of pancreatic adenocarcinoma. Journals of Clinical Oncology. (Submitted)


Mahajan, Ujjwal Mukund, Langhoff, Eno, Goni, Elisabetta, Costello, Eithne, Greenhalf, William, Halloran, CM ORCID: 0000-0002-5471-4178, Ormanns, Steffen, Kruger, Stephan, Boeck, Stefan, Ribback, Silvia
et al (show 19 more authors) (2018) Immune Cell and Stromal Signature Associated with Progression-free Survival of Patients with Resected Pancreatic Ductal Adenocarcinoma. Gastroenterology, 155 (05). 1625-1639.E2.


Ghaneh, Paula, Kleeff, Jorg, Halloran, CM ORCID: 0000-0002-5471-4178, Raraty, Michael, Jackson, Richard, Melling, James, Jones, Owain, Palmer, Daniel ORCID: 0000-0002-7147-5703, Cox, Trevor and Smith, Chloe
(2019) The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma. Annals of Surgery, 269 (03). pp. 520-529.


Elander, NO, Aughton, K ORCID: 0000-0002-5184-5789, Ghaneh, P, Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Cox, TF, Campbell, F, Costello, E, Halloran, CM ORCID: 0000-0002-5471-4178, Mackey, JR
et al (show 18 more authors) (2018) Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy. British Journal of Cancer, 118 (8). pp. 1084-1088.


Sheel, ARG, Baron, RD, Dickerson, LD ORCID: 0000-0001-6281-8658, Ghaneh, P, Campbell, F, Raraty, MGT, Yip, V, Halloran, CM ORCID: 0000-0002-5471-4178 and Neoptolemos, JP
(2019) The Liverpool duodenum-and spleen-preserving near-total pancreatectomy can provide long-term pain relief in patients with end-stage chronic pancreatitis. LANGENBECKS ARCHIVES OF SURGERY, 404 (7). pp. 831-840.


Sykes, PD, Neoptolemos, JP, Costello, E and Halloran, CM ORCID: 0000-0002-5471-4178
(2012) Nanotechnology advances in upper gastrointestinal, liver and pancreatic cancer. Expert Rev Gastroenterol Hepatol., 6 (3). pp. 343-356.


Muller, Nelly, Sarantitis, Ioannis ORCID: 0000-0002-3905-1417, Rouanet, Marie, de Mestier, Louis, Halloran, CM ORCID: 0000-0002-5471-4178 and Greenhalf, William
(2019) Natural history of SPINK1 germline mutation related-pancreatitis. EBioMedicine, 48. pp. 581-591.


Williams, D, Gana, T, Sivapalan, L, Butler, O, Jackson, R, Perez-Mancera, P, Barrera-Briceno, L, Copple, I, Cox, T, Goldring, C
et al (show 7 more authors) (2017) Nrf2 in Pancreatic Cancer Chemotherapy Response and the Use of Brusatol as a Chemotherapeutic Agent. .


Gomatis, I, Halloran, CM ORCID: 0000-0002-5471-4178, Ghaneh, P, Raraty, M, Polydoros, F ORCID: 0000-0001-5181-6817, Evans, JC, Smart, HL, Yagati-Satchidanand, R, Garry, JM, Whelan, PA
et al (show 3 more authors) (2016) Outcomes From Minimal Access Retroperitoneal and Open Pancreatic Necrosectomy in 394 Patients With Necrotizing Pancreatitis. Annals of Surgery, 263 (5). pp. 992-1001.


Halloran, CM ORCID: 0000-0002-5471-4178
(2017) Pancreatic Anastomosis After Pancreatoduodenectomy: A Position Statement By The International Study Group Of Pancreatic Surgery (ISGPS). Surgery, 161 (5). pp. 1221-1234.


Diener, Markus K, Hüttner, Felix J, Kieser, Meinhard, Knebe, Phillip, Dörr-Harim, Colette, Distler, Marius, Grützmann, Robert, Wittel, Uwe A, Schirren, Rebekka, Hau, Hans-Michael
et al (show 18 more authors) (2017) Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial. The Lancet, 390 (10099). pp. 1027-1037.


Rao, R Gopala, Costello, E, Halloran, CM ORCID: 0000-0002-5471-4178, Oldfield, L ORCID: 0000-0002-0839-402X, Greenhalf, W, Ghaneh, P, Neoptolemos, JP, Purewal, T, Evans, A and Mann, K
(2017) The Prevalence of Diabetes Mellitus is Significantly Higher for Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma Compared to Surgery for Other Pancreatic Pathologies. .


Halloran, CM ORCID: 0000-0002-5471-4178
(2020) Prognostic value of 18FDG PET-CT volumetric parameters in the survival prediction of patients with pancreatic cancer. Annals of Surgical Oncology, 46 (8). pp. 1532-1538.

This list was generated on Sun Apr 14 12:32:04 2024 BST.